期刊文献+

倍他乐克治疗慢性心力衰竭临床疗效观察 被引量:5

Clinical Therapeutic Effect Observation of Betaloc in Treating Chronic Cardiac Failure
暂未订购
导出
摘要 目的观察倍他乐克治疗慢性充血性心力衰竭(CHF)患者的疗效。探讨β-阻滞剂在CHF中的作用。方法将108例CHF患者在应用常规治疗的基础上加服倍他乐克,从12.5mg每天两次开始,直到目标剂量每天75mg,治疗6个月。观察内容为患者临床症状和体征,心功能(NYHA分级),左室射血分数,左室舒张末内径,运动耐量治疗前后的变化。结果倍他乐克可使心功能、左室射血分数提高,左室舒张末内径减少,明显改善运动耐量。结论倍他乐克可改善心功能提高生命质量。 Objective To observe curative effect of Betaloc in treating patients with chronic congestive cardiac failure. To investigate the effect of β-blocker on congestive cardiac failure. Methods 108 patients mild or moderate congestive cardiac failure were treated with conventional medical therapy and Betaloc(froml2.Smg twice a day to the objective dosage of 75mg/d),all the patients were treated for 6 months, clinical symptoms and sings of patients and the change of heart function (NYHA), LVEF,LVDD and exercise capacity from bace level before and after treatment were observed. Results Betaloc improve heart function,LVEF,reduee LVDD,improve exercise capacity obviously. Conclusion Betaloc improve heart function and quality of life.
出处 《中国现代医生》 2009年第34期46-47,共2页 China Modern Doctor
关键词 充血性心力衰竭 倍他乐克 心功能 左室射血分数 Congestive cardiac failure Betaloc Heart function LVEF
  • 相关文献

参考文献7

二级参考文献19

  • 1姚伟星.治疗充血性心力衰竭的药物及其进展[J].中国药师,2004,7(9):681-685. 被引量:11
  • 21.Packer M,Bristow M R,Cohn I N,et al.Effect of carvedilol on morbidity and mortality in chronic heart failure.N Engl J Med,1996,334:1349-1355.
  • 3CIBIS-Ⅱ investigators and committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS Ⅱ) a randomized trial.Lancet,1999,353(9146): 9-13.
  • 4MERIT-HF study group.Effect of metoprolo CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).Lancet,1999,353: 2001-2007.
  • 5Bristow M R.Mechanism of action of beta-blocking agents in heart failure.Am J Cardiol,1997,80(11A):26L-40L.
  • 6Bristow M R.Why does the myocardium fail? Insights from basic science.Lancet,1998,352(Suppl 1):8-14.
  • 7Pepper G S,Lee R W.Sympathetic activation in heart failure and its treatment with β-blockade.Arch Intern Med,1999,159(8):225-234.
  • 8Squire I B,Barnett D B.The rational use of β-adrenoceptor blockers in the treatment of heart failure.The changing face of an old therapy.Br J Clin Pharmacol,2000,49:1-9.
  • 9Eichhorn E J,Bristow M R.Medical therapy can improve the biological properties of the chronically failing heart.A new era in the treatment of heart failure.Circulation,1996,94(9):2285-2296.
  • 10Constant J.A review of why and how we may use β-blockers in congestive heart failure.Chest,1998,113:800-808.

共引文献2520

同被引文献36

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部